Neuromodulation for Depression. Invasive and Noninvasive (Deep Brain Stimulation, Transcranial Magnetic Stimulation, Trigeminal Nerve Stimulation).

Neurosurgery Clinics of North America

Volumn 25, Issue 1, 2014, Pages 103-116

  Cook, Ian A ^a   Espinoza, Randall ^a   Leuchter, Andrew F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Deep brain stimulation; Depression; Neuromodulation; Transcranial magnetic stimulation; Treatment resistant depression; Trigeminal nerve stimulation

Indexed keywords

BRAIN DEPTH STIMULATION; COMPARATIVE EFFECTIVENESS; DEPRESSION; EYE PAIN; HUMAN; INTERMETHOD COMPARISON; INVASIVE PROCEDURE; MAJOR DEPRESSION; NERVE STIMULATION; NEUROMODULATION; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; TOOTH PAIN; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; TRIGEMINAL NERVE STIMULATION; VAGUS NERVE STIMULATION;

DEEP BRAIN STIMULATION; DEPRESSION; NEUROMODULATION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT-RESISTANT DEPRESSION; TRIGEMINAL NERVE STIMULATION;

DEEP BRAIN STIMULATION; DEPRESSIVE DISORDER, MAJOR; ELECTRIC STIMULATION THERAPY; HUMANS; TRANSCRANIAL MAGNETIC STIMULATION; TRIGEMINAL NERVE;

EID: 84887953419     PISSN: 10423680     EISSN: 15581349     Source Type: Journal    
DOI: 10.1016/j.nec.2013.10.002     Document Type: Review

References (116)

1. Kessler R.C., Berglund P., Demler O., et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
2. World Health Organization The global burden of disease: 2004 update 2008, WHO Press, Available at:, Accessed October 25, 2013. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf.
3. Warden D., Rush A.J., Trivedi M.H., et al. The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep 2007, 9:449-459.
4. Rush A.J., Trivedi M.H., Wisniewski S.R., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006, 163(11):1905-1917.
5. Thase M.E., Rush A.J. When at first you don't succeed: sequential strategies for antidepressant nonresponders. JClin Psychiatry 1997, 58(Suppl 13):23-29.
6. Sackeim H.A. The definition and meaning of treatment-resistant depression. JClin Psychiatry 2001, 62(Suppl 16):10-17.
7. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003, 53:649-659.
8. Demitrack M.A., Thase M.E. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data. Psychopharmacol Bull 2009, 42:5-38.
9. Pallanti S. Images in Psychiatry: Ugo Cerletti 1877-1963. Am J Psychiatry 1999, 156(4):630.
10. Bolwig T.G. How does electroconvulsive therapy work? Theories on its mechanism. Can J Psychiatry 2011, 56:13-18.
11. Taliaz D., Nagaraj V., Haramati S., et al. Altered brain-derived neurotrophic factor expression in the ventral tegmental area, but not in the hippocampus, is essential for antidepressant-like effects of electroconvulsive therapy. Biol Psychiatry 2013, 74(4):305-312.
12. Ryan K.M., O'Donovan S.M., McLoughlin D.M. Electroconvulsive stimulation alters levels of BDNF-associated microRNAs. Neurosci Lett 2013, 549:125-129.
13. Fink M., Ottosson J.O. Atheory of convulsive therapy in endogenous depression: significance of hypothalamic functions. Psychiatry Res 1980, 2:49-61.
14. Rotter A., Biermann T., Stark C., et al. Changes of cytokine profiles during electroconvulsive therapy in patients with major depression. JECT 2013, 29(3):162-169.
15. 18F-FDG hypometabolism following electroconvulsive therapy in a major depressive episode. Clin Nucl Med 2013, 38(9):735-736.
16. Pfleiderer B., Michael N., Erfurth A., et al. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res 2003, 122:185-192.
17. Zhang J., Narr K.L., Woods R.P., et al. Glutamate normalization with ECT treatment response in major depression. Mol Psychiatry 2013, 18:268-270.
18. Sakaida M., Sukeno M., Imoto Y., et al. Electroconvulsive seizure-induced changes in gene expression in the mouse hypothalamic paraventricular nucleus. JPsychopharmacol 2013, 27:1058-1069.
19. Spellman T., Peterchev A.V., Lisanby S.H. Focal electrically administered seizure therapy: a novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction. Neuropsychopharmacology 2009, 34:2002-2010. [Erratum seems in 2012;37:1077].
20. Lisanby S.H., Schlaepfer T.E., Fisch H.U., et al. Magnetic seizure therapy of major depression. Arch Gen Psychiatry 2001, 58(3):303-305.
21. Kayser S., Bewernick B.H., Hurlemann R., et al. Comparable seizure characteristics in magnetic seizure therapy and electroconvulsive therapy for major depression. Eur Neuropsychopharmacol 2013, 10.1016/j.euroneuro.2013.04.011.
22. Zaghi S., Acar M., Hultgren B., et al. Noninvasive brain stimulation with low-intensity electrical currents: putative mechanisms of action for direct and alternating current stimulation. Neuroscientist 2010, 16:285-307.
23. Kalu U.G., Sexton C.E., Loo C.K., et al. Transcranial direct current stimulation in the treatment of major depression: a meta-analysis. Psychol Med 2012, 42:1791-1800.
24. Datta A., Dmochowski J.P., Guleyupoglu B., et al. Cranial electrotherapy stimulation and transcranial pulsed current stimulation: a computer based high-resolution modeling study. Neuroimage 2013, 65:280-287.
25. Berlim M.T., Van den Eynde F., Daskalakis Z.J. Clinical utility of transcranial direct current stimulation (tDCS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. JPsychiatr Res 2013, 47(1):1-7.
26. Delgado J.M. Free behavior and brain stimulation. Int Rev Neurobiol 1964, 6:349-449.
27. Delgado J.M., Mark V., Sweet W., et al. Intracerebral radio stimulation and recording in completely free patients. JNerv Ment Dis 1968, 147:329-340.
28. Andy O.J. Thalamic stimulation for control of movement disorders. Appl Neurophysiol 1983, 46:107-111.
29. Benabid A.L., Pollak P., Louveau A., et al. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 1987, 50:344-346.
30. Hauptman J.S., DeSalles A.A., Espinoza R., et al. Potential surgical targets for deep brain stimulation in treatment-resistant depression. Neurosurg Focus 2008, 25:E3. 10.3171/FOC/2008/25/7/E3.
31. Anderson R.J., Frye M.A., Abulseoud O.A., et al. Deep brain stimulation for treatment-resistant depression: efficacy, safety and mechanisms of action. Neurosci Biobehav Rev 2012, 36:1920-1933.
32. Hamani C., Nobrega J.N. Preclinical studies modeling deep brain stimulation for depression. Biol Psychiatry 2012, 72:916-923.
33. Dzirasa K., Lisanby S.H. How does deep brain stimulation work?. Biol Psychiatry 2012, 72:892-894.
34. Ramasubbu R., Anderson S., Haffenden A., et al. Double-blind optimization of subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study. JPsychiatry Neurosci 2013, 38:325-332.
35. Kennedy S.H., Giacobbe P., Rizvi S.J., et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry 2011, 168:502-510.
36. Cusin C., Dougherty D.D. Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS. Biol Mood Anxiety Disord 2012, 2:14. Correction: Biol Mood Anxiety Disord. 2013;3:1.
37. Reported by Cyberonics. Available at:. Accessed July 31, 2013. http://ir.cyberonics.com/releasedetail.cfm?ReleaseID=767670.
38. George M.S., Belmaker R.H. Transcranial magnetic stimulation in clinical psychiatry 2006, Amer Psychiatric Press, Arlington (VA).
39. Barker A.T., Jalinous R., Freeston I.L. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985, 1(8437):1106-1107.
40. George M.S., Wassermann E.M., Williams W.A., et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 1995, 6:1853-1856.
41. Kolbinger M.H., Höflich1 G., Hufnagel A., et al. Transcranial magnetic stimulation (TMS) in the treatment of major depression-a pilot study. Hum Psychopharmacol Clin Exp 1995, 10:305-310.
42. George M.S., Lisanby S.H., Sackeim H.A. Transcranial magnetic stimulation: applications in neuropsychiatry. Arch Gen Psychiatry 1999, 56:300-311.
43. George M.S., Wassermann E.M. Rapid-rate transcranial magnetic stimulation and ECT. Convuls Ther 1994, 10:251-254.
44. George M.S., Nahas Z., Molloy M., et al. Acontrolled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry 2000, 48:962-970.
45. Martin J.L., Barbanoj M.J., Schlaepfer T.E., et al. Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev 2002, (2). CD003493.
46. Slotema C.W., Blom J.D., Hoek H.W., et al. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. JClin Psychiatry 2010, 71:873-884.
47. Berlim M.T., Van den Eynde F., Jeff Daskalakis Z. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology 2013, 38:543-551.
48. Berlim M.T., van den Eynde F., Tovar-Perdomo S., et al. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med 2013, 10.1017/S0033291713000512.
49. O'Reardon J.P., Solvason H.B., Janicak P.G., et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007, 62:1208-1216.
50. Janicak P.G., O'Reardon J.P., Sampson S.M., et al. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. JClin Psychiatry 2008, 69:222-232.
51. George M.S., Lisanby S.H., Avery D., et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry 2010, 67:507-516.
52. Harel E.V., Rabany L., Deutsch L., et al. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: an 18-week continuation safety and feasibility study. World J Biol Psychiatry 2013, 10.3109/15622975.2011.639802.
53. Bersani F.S., Minichino A., Enticott P.G., et al. Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review. Eur Psychiatry 2013, 28:30-39.
54. Gaynes B.N., Lux L.J., Lloyd S.W., et al. AHRQ Comparative Effectiveness Review 33: nonpharmacologic interventions for treatment-resistant depression in adults. AHRQ Publication 11-EHC056-EF 2011, Agency for Healthcare Research and Quality, Rockville (MD), Available at:, Accessed October 25, 2013. http://effectivehealthcare.ahrq.gov/ehc/products/76/792/TRD_CER33_20111110.pdf.
55. Herbsman T., Avery D., Ramsey D., et al. More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biol Psychiatry 2009, 66:509-515.
56. Herwig U., Satrapi P., Schönfeldt-Lecuona C. Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr 2003, 16:95-99.
57. Beam W., Borckardt J.J., Reeves S.T., et al. An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain Stimul 2009, 2:50-54.
58. Herwig U., Padberg F., Unger J., et al. Transcranial magnetic stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation. Biol Psychiatry 2001, 50:58-61.
59. Peleman K., Van Schuerbeek P., Luypaert R., et al. Using 3D-MRI to localize the dorsolateral prefrontal cortex in TMS research. World J Biol Psychiatry 2010, 11:425-430.
60. Fitzgerald P.B., Hoy K., McQueen S., et al. Arandomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology 2009, 34:1255-1262.
61. Trojak B., Meille V., Chauvet-Gelinier J.C., et al. Further evidence of the usefulness of MRI-based neuronavigation for the treatment of depression by rTMS. JNeuropsychiatry Clin Neurosci 2011, 23:E30-E31.
62. Fox M.D., Liu H., Pascual-Leone A. Identification of reproducible individualized targets for treatment of depression with TMS based on intrinsic connectivity. Neuroimage 2012, 66C:151-160.
63. Carpenter L.L., Janicak P.G., Aaronson S.T., et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety 2012, 29:587-596.
64. Hadley D., Anderson B.S., Borckardt J.J., et al. Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. JECT 2011, 27:18-25.
65. Holtzheimer P.E., McDonald W.M., Mufti M., et al. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety 2010, 27:960-963.
66. URL Available at:. Accessed July 31, 2013. http://www.usatoday.com/story/news/2012/11/30/magnets-zap-depression/1738621/.
67. URL Available at:. Accessed July 31, 2013. http://www.icer-review.org/index.php/Announcements/maclcd.html.
68. American Psychiatric Association Practice guideline for the treatment of patients with major depressive disorder 2010, Amer Psychiatric Press Inc, Arlington (VA). 3rd edition, 10.1176/appi.books.9780890423387.654001.
69. Lisanby S.H., Husain M.M., Rosenquist P.B., et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 2009, 34:522-534.
70. George M.S., Taylor J.J., Short E.B. The expanding evidence base for rTMS treatment of depression. Curr Opin Psychiatry 2013, 26(1):13-18.
71. Bailey P., Bremer F. Asensory cortical representation of the vagus nerve. JNeurophysiol 1938, 1(5):405-412.
72. George M.S., Sackeim H.A., Rush A.J., et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry 2000, 47:287-295.
73. Ben-Menachem E., Mañon-Espaillat R., Ristanovic R., et al. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994, 35:616-626.
74. Handforth A., DeGiorgio C.M., Schachter S.C., et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998, 51:48-55.
75. Rush A.J., George M.S., Sackeim H.A., et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 2000, 47:276-286.
76. Aaronson S.T., Carpenter L.L., Conway C.R., et al. Vagus nerve stimulation therapy randomized todifferent amounts of electrical charge for treatment-resistant depression: acute and chronic effects. Brain Stimul 2013, 6:631-640.
77. Matheny R.G., Shaar C.J. Vagus nerve stimulation as a method to temporarily slow or arrest the heart. Ann Thorac Surg 1997, 63:S28-S29.
78. Reuter E., Krekeler G., Krainick J.U., et al. Pain suppression in the trigeminal region by means of transcutaneous nerve stimulation. Dtsch Zahnarztl Z 1976, 31:274-276. [in German].
79. Hellsing G. Transcutaneous neural stimulation (TNS) in chronic pain in patients with temporomandibular joint disorders. A clinical report. Tandlakartidningen 1976, 68:789-793. [in Swedish].
80. Augustinsson L.E., Bohlin P., Bundsen P., et al. Pain relief during delivery by transcutaneous electrical nerve stimulation. Pain 1977, 4:59-65.
81. Caous C.A., de Sousa Buck H., Lindsey C.J. Neuronal connections of the paratrigeminal nucleus: a topographic analysis of neurons projecting to bulbar, pontine and thalamic nuclei related to cardiovascular, respiratory and sensory functions. Auton Neurosci 2001, 94:14-24.
82. de Sousa Buck H., Caous C.A., Lindsey C.J. Projections of the paratrigeminal nucleus to the ambiguus, rostroventrolateral and lateral reticular nuclei, and the solitary tract. Auton Neurosci 2001, 87:187-200.
83. Gura E.V., Garkavenko V.V., Limansky YuP. Influences of central gray matter stimulation on thalamic neuron responses to high- and low-threshold stimulation of trigeminal nerve structures. Neuroscience 1991, 41:681-693.
84. Fanselow E.E. Central mechanisms of cranial nerve stimulation for epilepsy. Surg Neurol Int 2012, 3:S247-S254.
85. Schrader LM, Geist CL, DeGiorgio CM, etal. Regional PET activations with trigeminal nerve stimulation (TNS) and correlation with therapeutic response. American Epilepsy Society Annual Meeting online abstract 2.279. Available at:. Accessed October 25, 2013. http://www.aesnet.org/go/publications/aes-abstracts/abstract-search/mode/display?id=15012.
86. DeGiorgio C.M., Murray D., Markovic D., et al. Trigeminal nerve stimulation for epilepsy: long-term feasibility and efficacy. Neurology 2009, 72:936-938.
87. DeGiorgio C.M., Fanselow E.E., Schrader L.M., et al. Trigeminal nerve stimulation: seminal animal and human studies for epilepsy and depression. Neurosurg Clin N Am 2011, 22:449-456.
88. DeGiorgio C.M., Soss J., Cook I.A., et al. Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology 2013, 80:786-791.
89. Schrader L.M., Cook I.A., Miller P.R., et al. Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial. Epilepsy Behav 2011, 22:475-478.
90. Cook I.A., Schrader L.M., Degiorgio C.M., et al. Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy Behav 2013, 28:221-226.
91. Cook IA, DeGiorgio CM, Leuchter AF. Trigeminal nerve stimulation in post-traumatic stress disorder and major depression: a novel neuromodulation approach. NCDEU Annual Meeting. Poster I-7. Hollywood (FL), May 28-30, 2013.
92. Janicak P.G., Nahas Z., Lisanby S.H., et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul 2010, 3:187-199.
93. Rabheru K. Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how?. JECT 2012, 28(1):39-47.
94. Brunoni A.R., Valiengo L., Baccaro A., et al. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry 2013, 70:383-391.
95. Deng Z.D., Lisanby S.H., Peterchev A.V. Electric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs. Brain Stimul 2013, 6:1-13.
96. Tzabazis A., Aparici C.M., Rowbotham M.C., et al. Shaped magnetic field pulses by multi-coil repetitive transcranial magnetic stimulation (rTMS) differentially modulate anterior cingulate cortex responses and pain in volunteers and fibromyalgia patients. Mol Pain 2013, 9:33.
97. Rohan M., Parow A., Stoll A.L., et al. Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator. Am J Psychiatry 2004, 161:93-98.
98. Jin Y., Potkin S.G., Kemp A.S., et al. Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia. Schizophr Bull 2006, 32:556-561.
99. Leuchter A.F., Cook I.A., Jin Y., et al. The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Front Hum Neurosci 2013, 7:37.
100. Fuggetta G., Noh N.A. Aneurophysiological insight into the potential link between transcranial magnetic stimulation, thalamocortical dysrhythmia and neuropsychiatric disorders. Exp Neurol 2013, 245:87-95.
101. Mayberg H.S., Lozano A.M., Voon V., et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
102. Lozano A.M., Mayberg H.S., Giacobbe P., et al. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 2008, 64:461-467.
103. Neimat J.S., Hamani C., Giacobbe P., et al. Neural stimulation successfully treats depression in patients with prior ablative cingulotomy. Am J Psychiatry 2008, 165:687-693.
104. Lozano A.M., Giacobbe P., Hamani C., et al. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg 2012, 116:315-322.
105. Puigdemont D., Pérez-Egea R., Portella M.J., et al. Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression. Int J Neuropsychopharmacol 2012, 15:121-133.
106. Holtzheimer P.E., Kelley M.E., Gross R.E., et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry 2012, 69:150-158.
107. Malone D.A., Dougherty D.D., Rezai A.R., et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009, 65:267-275.
108. Malone D.A. Use of deep brain stimulation in treatment-resistant depression. Cleve Clin J Med 2010, 77(Suppl 3):S77-S80.
109. Schlaepfer T.E., Cohen M.X., Frick C., et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008, 33:368-377.
110. Bewernick B.H., Hurlemann R., Matusch A., et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 2010, 67:110-116.
111. Bewernick B.H., Kayser S., Sturm V., et al. Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence forsustained efficacy. Neuropsychopharmacology 2012, 37:1975-1985.
112. Jiménez F., Velasco F., Salin-Pascual R., et al. A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery 2005, 57:585-593.
113. Jiménez F., Velasco F., Salín-Pascual R., et al. Neuromodulation of the inferior thalamic peduncle for major depression and obsessive compulsive disorder. Acta Neurochir Suppl. 2007, 97(Pt 2):393-398.
114. Sartorius A., Kiening K.L., Kirsch P., et al. Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol Psychiatry 2010, 67:e9-e11.
115. Schlaepfer T.E., Bewernick B.H., Kayser S., et al. Rapid effects of deep brain stimulation for treatment-resistant major depression. Biol Psychiatry 2013, 73:1204-1212.
116. Kosel M., Sturm V., Frick C., et al. Mood improvement after deep brain stimulation of the internal globus pallidus for tardive dyskinesia in a patient suffering from major depression. J Psychiatr Res. 2007, 41:801-803.